Reports Compare Hinge Health to Competitors on Market Metrics
1 report, 1 independent
Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mid-cap healthcare companies, including Hinge Health, are currently competing in the market. One independent report compares Hinge Health to a competitor based on factors such as earnings, risk, and valuation. The report notes that Hinge Health has a beta of 1.38, indicating its stock price is 38% more volatile than the S&P 500.
From tickerreport.com
Why it matters
The comparison covers key business indicators including gross revenue, earnings per share, and net margins. The company's competitive positioning is being evaluated against industry benchmarks, including institutional ownership trends.
From tickerreport.com
Who's involved
- Hinge HealthHealthcare organization whose performance is being evaluated in market comparisons.
- Daniel PerezCo-founder and current CEO of Hinge Health.
- Morgan StanleyU.S. investment bank that provided analyst ratings and coverage for Hinge Health.
Keep exploring
The entities involved
-
Hinge Health
healthcare organization in San Francisco, United States